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Abstract
Background: Former inmates are at high risk for death from drug overdose, especially in the immediate post-
release period. The purpose of the study is to understand the drug use experiences, perceptions of overdose risk,
and experiences with overdose among former prisoners.
Methods: This qualitative study included former prison inmates (N = 29) who were recruited within two months
after their release. Interviewers conducted in-person, semi-structured interviews which explored participants’
experiences and perceptions. Transcripts were analyzed utilizing a team-based method of inductive analysis.
Results: The following themes emerged: 1) Relapse to drugs and alcohol occurred in a context of poor social
support, medical co-morbidity and inadequate economic resources; 2) former inmates experienced ubiquitous
exposure to drugs in their living environments; 3) intentional overdose was considered “a way out” given
situational stressors, and accidental overdose was perceived as related to decreased tolerance; and 4) protective
factors included structured drug treatment programs, spirituality/religion, community-based resources (including
self-help groups), and family.
Conclusions: Former inmates return to environments that strongly trigger relapse to drug use and put them at
risk for overdose. Interventions to prevent overdose after release from prison may benefit from including structured
treatment with gradual transition to the community, enhanced protective factors, and reductions of environmental
triggers to use drugs.
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Background
Over 7.2 million people were incarcerated or on proba-
tion/parole at year-end 2009 [1]. A history of drug use
or misuse is pervasive among prison inmates by every
measure, including prior use, use at the time the offense
is committed, drug abuse, and drug dependence [2-4].
Despite the magnitude of the problem of substance use
disorders among criminal justice populations, prisoners
have limited access to evidence-based substance abuse
treatment during incarceration, during the transition to
the community, or while under community supervision
[3,5-7]. Therefore, inmates are often released without
the tools to avoid returning to drugs after release from
prison.
Studies in the United States and other countries have
shown a high risk of drug-related death after release
from prison [8-19]. Overdose rates peak in the first few
weeks after release [8,20]. For instance, in prisoners
released in Washington State, overdose mortality rates
were 12-fold higher than what would be expected in
similar demographic groups in the general population.
In the first two weeks after release, the risk of overdose
was even greater, with an adjusted relative risk of 129
[20]. Accidental overdoses accounted for nearly one-
quarter of deaths post-release and were related to
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cocaine, other psychostimulants, opioids, alcohol, tricyc-
lic antidepressants, and multiple drugs in combination.
Suicide was the 4th leading cause of death and likely
included intentional overdoses [20].
Despite the epidemiologic data that describes a high
rate of death from overdose after release from prisons,
little is understood about the conditions that lead to
relapse and overdose after release. Prior studies have
shown that former inmates face challenges including
poor housing, unemployment, psychosocial problems
and barriers to health care [21-25]. We sought to better
define the risk and protective factors that impact drug
use and risk for overdose from the perspective of former
inmates in the immediate post-release period. This
information is essential to developing effective interven-
tions that reduce risk in a real-world context. Specifi-
cally, this study was designed to better understand the
drug-use experiences, perceptions, knowledge of over-




We conducted a qualitative study using face-to-face, in-
depth, semi-structured interviews with former inmates
aged 18 and older who were English speaking and could
understand study procedures. Former inmates who were
no longer in jail but who were on current inmate status
(i.e., living in the community but still considered prison-
ers) were excluded. We focused recruitment on former
inmates within two months of release from prison to
maximize recall. Interviews were scheduled as soon after
recruitment as possible. The mean length of time from
release to interview was 42 days (range, 5 to 82 days).
The final sample included 29 inmates. Details of our
interview methods with this sample have previously
been described [26,27]. The study was reviewed by the
Colorado Multiple Institutional Review Board. All parti-
cipants reviewed a consent form prior to participating in
the study.
Study setting
Participants were initially recruited from a community
health center, an urgent care center, and addiction
treatment centers in the Denver, Colorado area, with
subsequent snowball sampling (those who agreed to
participate were asked to tell their friends and acquain-
tances about the study) [28]. We recruited participants
by placing flyers and brochures in waiting areas and
examination rooms and informing providers about elig-
ibility criteria. Individuals who called inquiring about
the study had an initial eligibility screening by phone;
eligibility was confirmed in person prior to informed
consent. Eligibility criteria included ability to speak
English, ability to comprehend and consent to the study
procedures, and age ≥ 18 years. We excluded juveniles
because they have access to different post-release pro-
grams than adults. We also excluded current inmates
and those whose most recent release was from jails
(compared with prisons, these usually hold detainees
prior to sentencing or individuals serving short
sentences).
Interviews
The interview guide was developed by the authors and
included questions regarding challenges during the
immediate post-release period, health-care access, HIV
risk, overdose experiences, and drug use after release
[26,27]. This analysis includes data from all parts of the
interview, but focuses on direct questions on drug use
and overdose, e.g., “After being released from prison
(this time), have you used any illegal drugs or prescrip-
tion drugs you got on the street? (If so,) when was the
first time? What kind of drugs did you use? What led
you to use drugs since your release? How have you
avoided drugs since your release? What helped you the
most?” On the topic of overdose, we asked, “Some peo-
ple worry about overdosing on drugs when they get out
of prison, while others don’t worry about this. What
about you?” We also asked, “Have you had any personal
experiences with overdose after release from prison or
jail?” and, “Can you tell me about a time, or more than
one time, when you’ve seen or heard about someone
overdosing after their release?”
Interviews were conducted from March through June
2009. Two experienced interviewers (one male and one
female) were trained in interviewing criminal-justice
populations, qualitative methods, and behaviors to
increase rapport and participant comfort level. Team
members met periodically to debrief the interviewers.
The one-on-one interview format allowed participants
to express their ideas and experiences and avoid issues
of mistrust of groups [29,30]. Participants were provided
$25 in the form of a check or grocery gift card. Partici-
pants who agreed to be re-contacted to verify data inter-
pretation were compensated an additional $25 at the
follow-up interview. Interviews were digitally recorded
in a private setting, uploaded to a secure drive, and
transcribed by a professional transcriptionist.
Analysis
Interview transcripts were our primary data source.
Transcript files reviewed for accuracy and entered into
Atlas.ti© qualitative data analysis software. Additional
data included a brief demographic survey; interviewer
summaries detailing context, process, content, and self-
reflection; and notes from interviewer debriefing ses-
sions and informant feedback.
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We analyzed data using an inductive, team-based
approach previously described [26,27,31-33]. Two
coders reviewed the data, created primary codes, and
met with the team to discuss coding until consensus
was reached on a codebook. Subsequent analytic steps
included an iterative team process of data collection,
debriefing, and thematic analysis [29,34]. We presented
the results to external groups to further refine analysis.
The research team assisted with data interpretation,
prioritizing salient elements, and discussing discrepan-
cies and implications. Finally, we met with three parti-
cipants to clarify key points and assess validity of our
interpretations (informant feedback) [29]. The study
was approved by the Colorado Multiple Institutional
Review Board and obtained a Federal Certificate of
Confidentiality.
Results
Participants included 29 men (69%) and nine women
(31%) with a mean age of 39 years (range, 22-57 years).
Eleven participants (38%) described themselves as Afri-
can American, 10 (34%) as Caucasian, 5 (17%) as Latino,
and 3 (10%) as American Indian. The mean length of
time since release was 42 days (range, 5-82). Over half
of the participants (16/29) knew of someone who over-
dosed soon after release from prison, and three had per-
sonally overdosed during previous releases from prison.
In the course of their interviews, 16 participants
described living in shelters. The substances used by our
participants included cocaine/crack, heroin, methamphe-
tamine, marijuana, opioid-containing pain medications,
benzodiazepines, alcohol, and tobacco.
The re-entry context: social support, financial needs, and
other re-entry challenges
After release, return to drug and alcohol use occurred in
a context of poor social support and inadequate eco-
nomic resources to support integration into the commu-
nity. Social isolation was a particular problem for former
inmates who were trying to stay away from drugs and
alcohol. For instance, one former inmate explained:
“I just don’t go around nobody. It’s kind of hard
‘cause my whole family gets high.”
One participant described the need for social support
to avoid drug use after release from prison:
“They just don’t know what they’re really doing to
their body cause they killing themselves slowly but
surely and they need somebody to help them, you
know, the courage, and to tell them not to mess
around with it.”
Nearly all participants struggled with financial pro-
blems, and several participants described poor finances
as contributing to drug use and relapse:
“Most people relapse in the first six months because
it’s so stressful because they have no help. There’s no
financial help to even get housing or to... buy clothes
for work or a bus pass to even try to look for a job.”
Additionally, drug trafficking in the environment
where former inmates returned was considered a major
problem for participants, whether they used drugs after
release or not:
“With the mix of the people that have mental pro-
blems and the homeless, people that are, you know,
doing drugs and it’s just a mess down there [at the
shelter].... They stand out there and sell drugs all day
long on the corners and it’s like a safe zone down
there.... It’s totally out of control.”
In addition to the direct risk to former inmates of
using drugs, many participants described the risk of vio-
lence and theft related to drug trafficking as major
threats to their health and safety after release from
prison. Participants perceived themselves as at substan-
tial risk for assault and violence related to drugs and
alcohol:
“The biggest threat to my safety was the area that the
shelter is located in... I saw several very bad beatings.
Some guy got stabbed and almost killed for a pint of
vodka ‘cause he had it in his pocket and the drug
deals and just... it’s a very dangerous area.”
Overall, the multiple contextual challenges during re-
entry had a strong influence on the return to drugs and
alcohol after release from prison.
Medical and mental health conditions among drug- and
alcohol-involved former inmates
For some former inmates, medical and mental health
needs in the re-entry context were closely linked with
their drug and alcohol use disorders. Participants identi-
fied multiple comorbidities, such as diabetes, epilepsy,
hypertension, chronic pain, anxiety, and depression,
combined with limited access to care and medications.
One woman explained that the biggest threat to her
health after release was having diabetes related to alco-
hol use combined with poor medication continuity:
“[The biggest threat] to my health [after release]?
Drinking like the way I did, ‘cause I’m a diabetic
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and I shouldn’t be drinking like that.... I almost went
into a diabetic coma. My sugar was so high ‘cause...
the Department of Corrections didn’t release me with
my insulin.”
Another participant with a history of oxycodone and
heroin dependence described her difficulties obtaining
mental-health medications as contributing to strong
feelings of frustration after her release:
“The biggest threat to my health is the issue of trying
to get that medication and stuff taken care of and I
am really frustrated.... They’ll pay for so much of
your mental-health care after you get out and stuff
like that, and none of that’s happened yet, you know,
so I’m still without a psychiatrist at this point, you
know? And I have a month worth of [mental health]
medicine before that runs out....”
Another participant explained the effect of frustration
in the context on her drug and alcohol use:
“My biggest challenge [after release] is to not use
[drugs and alcohol] and not let... all of the frustra-
tion and stuff that you feel build up....”
Later in the interview, this same participant explained
that the contextual challenges she faced required that
she avoid drugs and alcohol:
“The challenges that I am facing right now in my life
cannot be handled without a clear mind. You know,
even if [I]drink, it affects me the next day.”
For the participants in this study, medical and mental-
health problems interacted with poor continuity in
health care, drug and alcohol use, and strong emotional
reactions including frustration.
Relapse and exposure to drugs and alcohol
Former inmates described ubiquitous exposure to alco-
hol, drugs, and drug trafficking in their living environ-
ments. In particular, former inmates who stayed in
homeless shelters found that it took substantial effort to
stay away from drugs and alcohol after release from
prison. One man in his mid-forties struggling to stay
abstinent from drugs after his release:
“You get asked 50 times if you want some coke before
you get into the [shelter] door.”
One 46-year-old man who had a place to live also
described frequent exposure to drugs:
“Well, when I first got out, peoples come around
asking me do you want this. Hey man, I remember
you, man you used to look out for me, here, here
you go. I said man, no I don’t want it. I been there.
I done it.”
Several participants with a history of addiction
described exposure to drugs as the major challenge they
faced, requiring avoidant behaviors and new skills to
prevent relapse. For instance, one man, whose drug
involvement led to his incarceration, had successfully
averted relapse since his release. He was motivated by a
desire to preserve a relationship with his son, born
while he was in prison. He practiced avoidant behaviors
at his shelter:
“There’s a lot of drug activity, kind of drug users and
stuff like that at the shelter, and it’s kind-of hard
there.... I mean, people will walk up to me and ask
me, oh, you want to buy some weed...? What are you
looking for? I try and avoid those situations, those
people; I said, no I’m not looking and just kind of
walk away and go to a different area or something
like that.... I’m really not tempted to use any drugs
right now because I’m trying to get my life on a
straight path but... people have offered to get me high
for free, hey you want to smoke, you want to hit this
pipe? You want to smoke a joint? You know, stuff
like that and just avoiding it, trying to, you know,
keep myself out of those situations is really the only
way I’ve been, you know, I focus.... I think about my
son, and drugs is really what took me into prison, so
I don’t want to use drugs ‘cause they will probably
take me back to prison, so I’m trying to stop myself
from going in a circle.”
Several participants described a return to drug use
within a short period of time after release from prison.
Participants described an overwhelming urge to use
drugs and alcohol to cope with frustration, “numb out,”
and “forget about” the daily stresses of the transition
period, citing easy availability combined with pressure
from old friends and new acquaintances to “party.” One
participant explained her use of cocaine, crack, alcohol,
and nonmedical benzodiazepines within one week of
release as follows:
“What led me to [use] this last time... was... frustra-
tion and wanting to feel released.... [I]t was some-
thing also that I didn’t go look for, that was right in
the house with me, and I don’t blame them for that,
but it’s just... I don’t think I would have sought it out
had it not been there.”
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Similarly, a young woman who had resumed intrave-
nous methamphetamine and cocaine use after a prior
release described why she relapsed:
“If you don’t go to [a therapeutic community] in
prison, then you never really stopped using. You just
stopped intaking it, so your body still wants it, your
mind still wants it, and it’s all you think about while
you’re in prison, but if you go to rehab and people
show you a different way of life, then you start think-
ing maybe I don’t want it. But most people who are
in prison are just waiting for their next hit.”
For a participant who had used drugs after prior
releases, the most significant challenge he faced was
staying away from individuals with whom he had pre-
viously used drugs:
“[The biggest problem is] not going back to the same
lifestyle that got me in prison, ‘cause I have seen
some of the old people that I used to hang out with,
and some of them are clean and sober and doing
good and some of them are still up to the same, but
you know, I still care about them. They’re my friends,
but I just... it was hard for me to like say ‘I need to
go,’ you know, cause I had spent so much time with
them over the years that now that some of them are
still getting high and still doing the things that they
do, it was hard for me to just say, ‘Hey, I can’t not
be your friend, but I just can’t be around you at this
time, because that’s just too much of a trigger for me
cause it’s just one little slip up and I go back’.... [T]
he hardest thing is not going back into the lifestyle
that got me put in prison and finding a job.”
In summary, the environments to which participants
returned immediately following prison made it difficult
to avoid relapse due to ubiquitous triggers to use. Despite
these risks, former inmates described protective factors
and responses such as strengthening family relationships,
changing social networks, and avoiding former lifestyles
to mitigate the risks of relapse and return to prison.
Perceptions of overdose after release from prison
We specifically sought to learn more from former
inmates about post-release overdose. Three participants
had personally experienced a post-release overdose, and
16 had either witnessed or known people who had such
overdoses. Most participants were aware of the dangers
of post-release overdose. The reasons most frequently
mentioned for overdose were the lack of knowledge
about lowered tolerance levels after limited access to
drugs during incarceration, the increase in potency level
of street drugs over years of incarceration, and
intentional overdose as a means of coping with stress
and anxiety that seemed unbearable.
“The last time I OD’d, I was on parole. I did too
much. I went back to my normal dosage, what I was
doing before I went in and that didn’t work.... I
wound up in intensive care three days later from a
coma.... I know that when you come out of [the
Department of Corrections] your body is clean so...
you need to be careful and know what you’re doing...
and you never know what you get.”
One participant in his mid-fifties experienced fatal
overdose among six of his friends and acquaintances.
He described the trend of early deaths after release from
prison as follows:
“I’ve lost quite a few friends that have came out and
were very fresh to this street life, and they OD’d on
heroin you know. Just a sad thing. Of course they
had only been out a couple weeks.”
Several described the overdoses of friends or acquain-
tances as being related to the stress of release, difficulty
adhering to parole conditions, a sense of hopelessness,
and a lack of ability to cope with the transition:
“It [overdose] would have to be on purpose, because
parole makes it so difficult to make it.”
As a result, overdose was considered by other several
participants to be a mechanism for committing suicide
to end such stress. One man who was interviewed five
weeks after release described overdose as choosing
death over going back to prison:
“It’s like they purposely want you to screw up so you
go back.... If I foul up, they’re going to file escape
charges on me... that’s 48 years off the top. I’m going
back for the rest of my life. I would... rather die than
go back and give them 48 years of my life. So, it’s
like... you got a choice. Go back to prison for the rest
of your life or die. They going to choose death.”
Thus, overdose was considered a physiologically dri-
ven phenomena–a coping mechanism (albeit poor) for
the seemingly insurmountable challenges faced by for-
mer inmates and a “way out” if the challenges became
too great.
Available services and other strategies employed by
former inmates
The most commonly cited substance-abuse services
available to participants after release from prison were
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drug and alcohol classes. Many participants also had to
undergo urine toxicology screens through their case-
management programs or parole offices. The parole
office was perceived as structured around enforcement
rather than assistance but, nonetheless, some partici-
pants obtained services and support from their parole
officer. Participants also described re-entry services and
community-based case management services as helpful
in general. For instance, one participant identified his
parole officer and Treatment Accountability for Safer
Communities (TASC) case manager as helpful:
“Staying in touch with my parole and with my TASC
lady, staying in touch with her.”
Participants identified factors that protected them
from returning to drug use, including avoidance of old
neighborhoods, strong family relationships, religion and
spirituality, housing, support from friends, a highly
structured residential treatment program, a patient navi-
gator, community-based organizations and programs,
and self-help groups such as Alcoholics Anonymous
(AA) and Narcotic Anonymous (NA). In response to a
question about what has helped her avoid using drugs
since release, a woman with a history of opioid depen-
dence described the following community resources:
“[I] got involved, like, with Empowerment [a commu-
nity-based organization], gone to church, been to
some meetings like AA, NA, and talked to, like, my
mom and stuff about it... been more open with people
and not hiding it, except from my parole officer, of
course (laughing), you know.”
Housing away from shelters, with their associated drug
use and trafficking, was of foremost importance to our
participants.
“There’s a lot of drugs, there’s a lot of alcohol in
those shelters and there should be some statutes per-
taining to individuals like myself that had to parole
homeless... to get housing somewhere once we’re
released.”
One 26-year-old woman explained that a highly struc-
tured transitional residential program, paid for by the
Department of Corrections, prevented her relapse.
“If I’d been in the real world, I probably would have
relapsed already, but being because I am in this
structured environment [residential drug treatment
facility] and I have the support I need, I haven’t
relapsed; but if anybody is an addict and they are
out there without the support, it’s a probably nine-to-
one chance that they’re going to relapse.”
Participants described learning from prior releases,
which helped them through the re-entry period in their
most recent release. One young woman described a long
process of re-learning how she dressed and presented
herself to others in order to avoid relapse after release
from prison, with the assistance of a structured pro-
gram:
“It’s the way you act, the way you present yourself,
[your] perception, you know? And it all has to be re-
learned cause it’s not... that you say one day, ‘I want
to be a dope dealer’ (laughing), you know? It’s some-
thing that happens with time, and everything has to
be re-learned.”
Despite the tremendous challenges faced by former
inmates, a number of participants expressed hope about
their prospects and willingness to work to maintain
their sobriety and avoid relapse:
“I haven’t been sober this long for a long time, so now
then I’m back out and re-integrating into the com-
munity, it’s kind of weird, because I didn’t know how
to have sober fun. I didn’t know how to communicate
with people without being high on drugs or drunk
or... so, it’s a new experience and it’s kind of hard,
but then at the same time, it’s just... it’s another
challenge that I’m willing to take on.”
Discussion
Despite the high prevalence of substance use disorders
among individuals in prison, our results suggest that for-
mer inmates with a history of drug use disorders and
criminal drug charges are often released into environ-
ments with significant social and economic challenges,
little structure, and ubiquitous drug activity. These chal-
lenges made it difficult for former inmates with drug
use disorders to remain abstinent from drugs and
alcohol.
Participants described a re-entry context of poor social
and family support, financial insecurity, and inadequate
housing. In this context, repeated triggers to use drugs
in individuals who are predisposed to substance use dis-
orders makes it difficult for them to succeed at main-
taining sobriety upon re-entry. The immediate return to
drug use described by some of our participants suggest
that despite prolonged periods of relative abstinence in
prison, the pervasive environmental stimuli experienced
by former inmates with substance use disorders in the
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community encourages return to drug use and heightens
the risk of overdose. Community-based programs, tran-
sitional housing, and other re-entry interventions should
consider the need to reduce triggers for drug use to
minimize the risk of relapse and overdose among former
inmates (Table 1).
In addition to the effects of strong stimuli on former
inmates with drug-use histories, the medical, psychoso-
cial and economic challenges former inmates experience
fuel a desire to use drugs and alcohol. Overdose was fre-
quently perceived of as intentional, as a choice or “way
out of” unbearable conditions. This suggests former
inmates needed assistance to cope with the stress of
transition in order to prevent intentional overdoses.
Former inmates widely described decreased tolerance
as a mechanism for accidental overdose. For drugs other
than opiates, biological support for this belief is lacking.
Nonetheless, opioid replacement programs initiated
either in prison or at release as well as distribution of
antidote (e.g., naloxone) to former inmates both have
the potential to prevent fatal overdoses [35,36].
In our study, former inmates identified several inter-
ventions and resources they found helpful to the main-
tenance of sobriety and prevention of overdose in the
early post-release period. These included motivation to
preserve family relationships, especially with children;
support from organized religions; spirituality; housing at
a distance from shelters; support from friends; highly
structured residential treatment programs; community
resources and organizations; and 12-step programs.
Implications of our findings for the design of interven-
tions and policies are described in Table 1.
Access to existing resources should be encouraged
and supported. Highly structured programs that
provide gradual re-integration of former inmates with
drug use disorders into the community offer promise
as a means to minimize the pervasive drug exposures
they face and encourage new learned behaviors and
habits. Although structured programs may require sig-
nificant public investment, in light of costs associated
with criminal behavior in relation to drug use and sub-
sequent incarceration, such programs may be cost-
effective. Finally, programs to reduce relapse and over-
dose in the early post-release period should consider
addressing the economic, housing, and medical needs
of former inmates to reduce the stress related to these
challenges.
This study has several limitations. Qualitative data
provide depth to the understanding of a problem rather
than breadth [29,37]. Therefore, these results may not
be generalizable to all former inmates from all correc-
tional systems. As homelessness is common among for-
mer inmates, many of our participants lived in shelters;
thus, our study may not have reflected the experiences
of individuals in other housing categories. Our inter-
views were limited to English-speaking individuals with
the capacity for scheduling and attending interviews.
There may have been limited disclosure of drug use, but
many of our participants were forthcoming about their
drug-use histories. Although some participants had pre-
viously experienced overdoses after release and in other
contexts, none of the participants had experienced an
overdose during this release, which may have limited
our ability to gain timely and detailed information about
the circumstances which led to overdose. Finally, some
of our participants generalized about their peers being
released from prison; these statements may not accu-
rately reflect the experiences of those peers.
Table 1 Themes and Implications for Design of Interventions and Policies to Minimize Drug Relapse and Overdose
Risk among Former Prison Inmates
Theme Implication for Designs of Interventions and Policies
Relapse occurred in the context of poor social support, re-entry
challenges and lack of financial resources.
Attention to the psychosocial and practical needs of re-entry is necessary
to reduce risk.
Participants reported medical and mental-health problems combined
with limited access to health care and medications.
Re-entry services should include attention to meeting basic medical needs.
Participants described ubiquitous exposure to drugs, alcohol, and drug
trafficking in the environments to which they were released.
Transitional housing should be away from neighborhoods with ubiquitous
drug activity. Encourage avoidant behaviors and skills to avoid exposure.
Perception of high risk of overdose after release from prison because of
diminished tolerance.
Educate inmates about lower drug tolerance at release and provide
bystander naloxone training and distribution.
Overdose perceived as a means of coping with unbearable stress and
anxiety.
Teach new coping mechanisms for the stress and anxiety that
accompanies release.
Relapse after release perceived as a coping mechanism for depression,
anxiety, and frustration.
Enhance coping skills and ensure medication continuity for mental-health
conditions. Motivate inmates to seek and preserve healthy relationships for
support. Connect inmates with religious/spiritual institutions and
community-based organizations.
Preventive factors included structured drug-treatment programs,
spirituality/religion, community-based services, self-help programs, and
family.
Offer inmates structured treatment for substance use disorders after
release, help them link to community-based services, encourage use of
self-help programs, and support positive family roles and relationships.
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Conclusions
Our study offers the perspectives of former inmates on
the return to drug use and overdose during the post-
release period. Participants highlighted the significance
of poor social support, medical problems, and inade-
quate financial resources to support integration into the
community. Furthermore, they experienced ubiquitous
exposure to drugs in the neighborhoods to which they
were released. Intentional overdose was identified as “a
way out” in the context of significant situational stres-
sors, whereas accidental overdose was perceived as relat-
ing to decreased tolerance due to reduced drug
exposure during incarceration. Finally, former inmates
identified factors that prevented relapse and overdose,
including structured drug-treatment programs, spiritual-
ity/religion, and family. These results point to several
considerations for the design and implementation of
interventions in the immediate post-release period.
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